A B-cell Subset Uniquely Responsive to Innate Stimuli Accumulates in Aged Mice
Overview
Affiliations
We have discovered a distinct mature B-cell subset that accumulates with age, which we have termed age-associated B cells. These cells comprise up to 30% of mature B cells by 22 months. Despite sharing some features with other mature B-cell subsets, they are refractory to BCR and CD40 stimulation. Instead, they respond to TLR9 or TLR7 stimulation and divide maximally on combined BCR and TLR ligation, leading to Ig production and preferential secretion of IL-10 and IL-4. Although similar to follicular B cells in both B-lymphocyte stimulator (BLyS) receptor expression and BLyS binding capacity, these cells do not rely on BLyS for survival. They are neither cycling nor the result of intrinsically altered B lymphopoiesis in aged BM, but instead appear to be generated from mature B cells that exhaustively expand during the individual's lifetime. Finally, they present Ag effectively and favor polarization to a TH17 profile. Together, these findings reveal that while the magnitude of the mature primary B-cell niche is maintained with age, it is increasingly occupied by cells refractory to BCR-driven activation yet responsive to innate receptor stimulation.
Immunosenescence promotes cancer development: from mechanisms to treatment strategies.
Wang L, Tang D Cell Commun Signal. 2025; 23(1):128.
PMID: 40065335 PMC: 11892258. DOI: 10.1186/s12964-025-02082-6.
Li W, Zhang Z, Kumar S, Botey-Bataller J, Zoodsma M, Ehsani A Nat Aging. 2025; .
PMID: 40044970 DOI: 10.1038/s43587-025-00819-z.
B cell immunometabolism in health and disease.
Martinis E, Tonon S, Colamatteo A, La Cava A, Matarese G, Pucillo C Nat Immunol. 2025; 26(3):366-377.
PMID: 39984733 DOI: 10.1038/s41590-025-02102-0.
Age-Associated B Cells in Autoimmune Diseases: Pathogenesis and Clinical Implications.
Xie G, Chen X, Gao Y, Yang M, Zhou S, Lu L Clin Rev Allergy Immunol. 2025; 68(1):18.
PMID: 39960645 PMC: 11832777. DOI: 10.1007/s12016-025-09021-w.
Targeting B and T Lymphocyte Attenuator Regulates Lupus Disease Development in NZB/W Mice.
Gherardi L, Aubergeon L, Sayah M, Fauny J, Dumortier H, Monneaux F Immunotargets Ther. 2025; 14():7-23.
PMID: 39845702 PMC: 11750947. DOI: 10.2147/ITT.S490573.